I think it has to do with the sample to staff ratio. It's not enough to observe human subjects. You have to actively prevent them from going off the rails. It doesn't scale well when you increase the sample size. I guess we could replicate a similar experiment n-times and then do a meta study, but it's not ideal either.
How would you tackle the logistics of scaling up the above experiment?
I don't know how to fix the nutritionist studies- I'm still pretty skeptical that you could ever control enough variables to make any sort of conclusion around things with tiny effect sizes. This isn't like nutritional diseases we've seen in the past, for example if you look at a disease like pellagra (not getting enough niacin), literally tens of thousands of people died over a few years (beri beri, rickets, scurvy are three other examples; these discoveries were tightly coupled to the discovery of essential nutrients, now called vitamins).
https://pubmed.ncbi.nlm.nih.gov/29030361/ (N=16)
https://pubmed.ncbi.nlm.nih.gov/28814432/ (N=17)
https://ard.bmj.com/content/83/Suppl_1/1145.2 (N=21)
Of course, these are not nutritional studies.
It's also indicated for use in a disease we don't understand, for people who didn't respond to all the previously approved drugs. Not a good example at all.
Cimzia has been well-studied, and we understand why it works on autoimmune diseases like inflammatory arthritis. It has 6 FDA approvals for different indications, so your description of the drug itself is incorrect.
Because it's really hard and expensive to do such studies with more participants
Did they eat the same amount of calories or more calories? People will eat more of tasty food and less of bland food. You could get the inverse result by giving bland ultra-processed food and tasty unprocessed food.